Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 95,492

Document Document Title
WO/2017/002733A1
The purpose of the present invention is to provide: an expression vector capable of expressing, with higher expression efficiency, a protein derived from an exogenous structural gene through genetic engineering by using a yeast belonging...  
WO/2017/004545A1
Certain embodiments are directed to methods and compositions for preventing treating bacterial infections. In certain embodiments the compositions comprise thioredoxin deficient bacteria.  
WO/2017/002422A1
In order to cut a plurality of clumps having substantially uniform shapes and dimensions out of a propagated cell aggregate and appropriately eliminate contamination by fragments of different shapes or dimensions, when cutting a pluralit...  
WO/2017/004577A1
A cell-based assay for identifying a compound that inhibits iron transport in Gram-negative bacteria, engineered bacterial cells, and kits for conducting the same. The assay involves contacting a candidate compound with an engineered Gra...  
WO/2017/002962A1
The present invention addresses the problem of acquiring microorganisms that generate biominerals under high salt concentration conditions and establishing a new radionuclide recovery method in which dissolved strontium (Sr) is solidifie...  
WO/2017/001590A1
The present invention relates to a composition comprising at least one carrier comprising a polysaccharide, at least one antioxidant and at least one amino acid selected from cysteine, lysine, alanine and arginine. It also relates to the...  
WO/2017/002896A1
The present invention addresses the problem of providing: a glucose dehydrogenase; a polynucleotide encoding the enzyme; a method for producing the enzyme; a method for measuring glucose using the enzyme; a measurement reagent compositio...  
WO/2017/002929A1
[Problem] The purpose of the present invention is to effectively utilize microorganisms having the function of accelerating the growth of plants, especially plants of the family Lemnaceae. [Solution] The present invention provides a meth...  
WO/2017/002861A1
The present invention pertains to a cell preservative solution. The present invention also pertains to a method for preserving cells, a method for preparing fixed cells, and a method for analyzing cells using a cell preservative solution...  
WO/2017/002977A1
According to the disclosure of the description of the present invention, provided is a method for inducing genetic recombination. According to the description, provided is a step for causing a protein having DNA double helix-severing act...  
WO/2017/000870A1
Provided are a humanized lactate dehydrogenase (LDH) Saccharomyces cerevisiae and the construction method thereof. In particular, the method of gene homologous recombination is used to knockout the genes PDC1, PDC5 and PDC6 which encode ...  
WO/2017/003103A1
The present invention relates to novel separated Pseudomonas stutzeri, which enables deamidation of an amino compound, and a method, for deamidating an amino compound, using same.  
WO/2017/000249A1
This invention relates to novel probiotic Bifidobacteria strains, particularly, a B. pseudocatenulatum strain, and its use as probiotic, and food products, feed products, dietary supplements and pharmaceutical formulations containing the...  
WO/2016/209183A1
The present invention proposes a cellulose hydrolysis method including contacting a fermentation medium comprising paper sludge as carbon source with cellulase obtained on site from cellulase bacteria, until the mean glucose monomer numb...  
WO/2016/210154A1
This invention provides compositions and methods for providing high product yield of transgenes expressed in cyanobacteria and microalgae.  
WO/2016/209806A1
Described herein are methods and compositions for the induction of the production of regulatory T cells and for the treatment and/or prevention of diseases associated with pathological immune responses, such as inflammatory bowel diseases.  
WO/2016/208492A1
Provided is a novel xylanase having a high xylanase activity. A protein that comprises an amino acid sequence described in (a), (b) or (c) and has a xylanase activity: (a) an amino acid sequence corresponding to the amino acids at the 23...  
WO/2016/210373A3
The present disclosure provides methods for treating a disease or disorder by administering a programmed recombinant bacterial cell to a subject, wherein the programmed recombinant bacterial cell expresses a heterologous gene in response...  
WO/2016/208747A1
The present invention addresses the problem of obtaining an animal cell composition having a certain thickness by a simple and low-cost method. Specifically, the purpose of the present invention is to provide a method for eliminating the...  
WO/2016/207893A1
The present invention provides a nucleic acid molecule comprising: DGAT1 promoter or an active fragment thereof, the ammonium transporter promoter or an active fragment thereof, or the putative purine permease promoter or an active fragm...  
WO/2016/209117A1
The invention relates to microbiology, and more particularly to nutrient media used for cultivating bacteria for the subsequent study thereof. A nutrient medium comprising a pancreatic digest of casein, a peptic digest of meat, a heart p...  
WO/2016/207744A1
The present disclosure provides a culture medium capable of being used for clonal growth of Streptococcus pneumoniae to produce capsular pneumococcal polysaccharide for vaccine production, wherein the culture medium can include KH2PO4, N...  
WO/2016/209883A1
Provided herein are non-naturally occurring microbial organisms having biosynthetic pathways for production of target products and one or more genetic modifications that reduce a byproduct of the biosynthetic pathway. Compositions of tar...  
WO/2016/208754A1
The purpose of the present invention is to produce a chimeric antigen receptor (CAR) specific to glypican-1 (GPC-1) and to treat squamous cell carcinoma with genetically modified cells capable of expressing the CAR. The present invention...  
WO/2016/210076A1
Process for enhancing production rates/production of yeast cell wall products and yeast extracts by adding saponin or a saponin containing ingredient to yeast cultures during fermentation or to yeast cream prior to autolysis. In the cont...  
WO/2016/207869A1
The present disclosure relates to compound of the formula I wherein R1 is a halogen; R2, R4 are independently selected from a group consisting of C1–C6 alkyl, H, COCH3, COH, CO-alkyl, CO-aryl; R3 is a C3–C30 alkyl; or a pharmaceutica...  
WO/2016/207859A1
This invention provides a system of providing and a process of creating personalized immunotherapeutic compositions for a subject having a disease or condition, including therapeutic vaccine delivery vectors comprising gene expression co...  
WO/2016/209721A1
A microbial mat is provided, including a contact layer; a core layer; a matrix of cellulose fibers coated with a liquid nutrient mix; and a carrying sheet; wherein the core layer comprises the matrix of cellulose fibers coated with a liq...  
WO/2016/208332A1
A tumor vaccine that can be administered orally can be provided using a transformed bifidobacterium which can express/present WT1 protein. WT1 protein expressed/presented by the transformed bifidobacterium is a protein which can cover a ...  
WO/2016/209776A1
A method of and a system for controlling the culture growth of high value feed organisms in a co-fermented system that produces ethanol and for the culture to consume both nonprotein and carbohydrate based products. The method and system...  
WO/2016/210373A2
The present disclosure provides methods for treating a disease or disorder by administering a programmed recombinant bacterial cell to a subject, wherein the programmed recombinant bacterial cell expresses a heterologous gene in response...  
WO/2016/208861A1
The present invention relates to a Streptomyces badius SP6C4 strain isolated from strawberry pollen and having an antibacterial activity against insect pathogens, and a use thereof. In the present invention, it was verified that the Stre...  
WO/2016/205276A1
The invention relates to the methods for modifying the methylation pattern of bacteriophage DNA and phagemid DNA and to methods for selective killing of bacteria using lysogenic bacteriophages comprising bacteriophage DNA or phagemid DNA...  
WO/2016/203220A1
The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.  
WO/2016/203221A1
The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.  
WO/2016/203217A1
The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.  
WO/2016/203223A1
The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.  
WO/2016/205554A1
Disclosed are compositions and methods for directing proteins to specific loci in the genome and uses thereof. In one aspect, the disclosed methods allow for directing proteins to specific loci in the genome of an organism, including the...  
WO/2016/203218A1
The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.  
WO/2016/203004A1
The invention relates to a method for obtaining a mutant Yarrowia yeast strain capable of growing on D-galactose as sole carbon source, comprising over expressing in said strain a galactokinase, a galactose- 1-phosphate uridyl transferas...  
WO/2016/205596A1
Disclosed are methods and systems for propagating microorganisms such as yeast using a carbon source that includes glycerol and a nutrient source that includes a stillage component.  
WO/2016/204265A1
The present invention pertains to a method for measuring complement-dependent bactericidal function with respect to pneumococci, and provides a method for measuring activity which can perform measurements with respect to all capsular ser...  
WO/2016/201825A1
Provided are an immunogenicity composition comprising mycobacterium tuberculosis antigens Rv0976c, Rv1255c, Rv3160c and/or Rv0792c and coding genes thereof, vaccines or a treatment composition.  
WO/2016/199966A1
The present invention relates to a lactic acid-producing Saccharomyces sp. microorganism having a weakened pyruvate decarboxylase (PDC) activity and enhanced aldehyde dehydrogenase (ALD) and acetyl-CoA synthetase (ACS) activities, and a ...  
WO/2016/199552A1
The purpose of the present invention is to provide a cell culture vessel from which cells can be detached when a temperature or a pH value in the cell culture vessel is changed. The present invention is a cell culture vessel for culturin...  
WO/2016/201031A1
A simple process for converting lignocellulosic biomass into fermentation products is disclosed. Biomass may be subjected to a steam or hot-water soak to dissolve hemicelluloses. This step is followed by mechanical refining, such as in a...  
WO/2016/198697A1
The present invention relates to a method for manipulating the evolution of collectives of self-replicating entities, in a high throughput droplet milli-fluidic system.  
WO/2016/201380A9
The present disclosure provides recombinant bacterial cells that have been engineered with genetic circuitry which allow the recombinant bacterial cells to sense a patient's internal environment and respond by turning an engineered metab...  
WO/2016/199090A1
The invention relates to a method of obtaining a preparation containing killer toxins, involving yeasts of the Debaryomyces hansenii species, the preparation being useful in an integrated and ecological protection of fruit plants, crops ...  
WO/2016/201174A2
Provided herein, in some aspects, are tools (e.g., methods, compositions and nucleic acids) for building genetic circuits in Bacteroides and Parabacteroides bacteria, as well as the bacteria containing the genetic circuits.  

Matches 301 - 350 out of 95,492